Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

EPAS1 Gene Erythrocytosis (Familial Type 4) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين EPAS1 للكثرة الحمر العائلية من النوع الرابع (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

ملخص تنفيذي: فحص جيني متطور لطفرة EPAS1 بدقة تشخيصية تبلغ 99.9% وشهادة ISO 9001:2015.

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
  • Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Overview

This advanced genetic test analyses the entire EPAS1 gene using Next-Generation Sequencing (NGS) to diagnose familial erythrocytosis type 4 with precision. يكشف التحليل الطفرات المسببة لكثرة الحمر العائلية من النوع الرابع عبر تقنية التسلسل الجيني المتقدم.

Feature Our NGS Test Closest Alternative (Sanger Sequencing)
Precision Full gene coverage, CNV detection, >99.9% sensitivity Targeted mutation analysis only, may miss novel variants
Method NGS (Illumina NovaSeq) with multi-exon deletion/duplication Capillary electrophoresis, limited variant detection
Speed 3–4 Weeks 2–3 Weeks (incomplete picture)
Cost 2800 AED ~1500 AED (limited clinical utility)

Physician Insight & Safety Protocol

“This genetic test is crucial for confirming familial erythrocytosis type 4, but results must be correlated with clinical and laboratory findings to guide management. I emphasize that a positive EPAS1 mutation does not always predict severity, and regular monitoring is essential.”

Dr. PRABHAKAR REDDY (DHA Licence: 61713011), Consultant Hematologist

Medication Warning: Do not discontinue prescribed medication without consulting your doctor.

Safety Exclusion Criteria & Emergency Red Flags

  • Acute febrile illness or active infection on the day of sample collection.
  • Known severe anemia or bleeding disorder not disclosed prior to phlebotomy.
  • Therapeutic anticoagulation without prior written consent from the treating physician.
  • Minors must be accompanied by legal guardian; guardian consent mandatory per Federal Decree-Law No. 41 of 2024 and UAE CDS Law 2026 (Minors).
  • Go to the nearest ER if you experience: sudden severe headache, blurred vision, chest pain, shortness of breath, or unusual bleeding/swelling at the puncture site after sample collection.

Patient FAQ & Clinical Guidance

Q: What is the EPAS1 gene test for?

س: ما هو الهدف من اختبار جين EPAS1؟

A: The EPAS1 Genetic Test identifies germline mutations responsible for familial erythrocytosis type 4, guiding accurate diagnosis and family screening.

ج: يكشف اختبار EPAS1 NGS عن الطفرات الجينية المسببة لكثرة الحمر العائلية من النوع الرابع بدقة تتجاوز 99.9%، مما يساهم في التشخيص والفحص الأسري.

Q: How accurate is the test?

س: ما مدى دقة هذا الاختبار؟

A: Our NGS test delivers >99.9% analytical sensitivity and specificity for EPAS1 variants, confirmed by ISO 9001:2015 validation.

ج: يوفر اختبار التسلسل من الجيل التالي حساسية ونوعية تحليلية تزيد عن 99.9% لمتغيرات EPAS1، وفقًا للتحقق المعياري ISO 9001:2015.

Q: Is home sample collection available in the UAE?

س: هل تتوفر خدمة سحب العينات من المنزل في الإمارات؟

A: Yes, we provide ISO-certified cold-chain home phlebotomy across the UAE from 8 AM to 11 PM, maintaining sample integrity.

ج: نعم، نقدم خدمة سحب الدم المنزلي بنظام التبريد المعتمد من ISO في جميع الإمارات من 8 صباحًا حتى 11 مساءً، مع الحفاظ على جودة العينة.

Pre‑ Requirements

  • A detailed clinical history of the patient, including previous hematological events and family history of erythrocytosis.
  • Mandatory genetic counselling session to draw a pedigree chart of family members affected with EPAS1‑related erythrocytosis.
  • Samples accepted: Whole Blood (2–5 mL in EDTA tube), Extracted DNA, or One drop of blood on FTA Card.

ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | UAE PDPL Compliant | DHA Facility Licence: 9834453

Methodology: Next-Generation Sequencing (Illumina NovaSeq), LC‑MS/MS validated quality control. ICD‑10‑CM Codes: D75.0 (Familial erythrocytosis), D75.1 (Secondary polycythemia), Z15.89 (Genetic susceptibility). LOINC: 82939‑0 (EPAS1 gene mutations found).

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians